EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Lower Risk of Acute Kidney Injury in Hospitalized Patients Treated with SGLT-2 Inhibitors: A Retrospective Matched Cohort Study

Dion Gabriël Lodewijk de Martines, Kenan Hasan Ali Aydinoglu, Christina Gant, Ytzen Westra, Kim de Jong, Aaltje Ymkje Adema

American Journal of Nephrology · 27.04.2026 · 1-10

DOI: 10.1159/000551925 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift American Journal of Nephrology, online erschienen am 27.04.2026. Verfasst von Dion Gabriël Lodewijk de Martines und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, University Medical Centre Utrecht, Utrecht, The Netherlands, d.g.l.demartines@umcutrecht.nl. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Recent studies have shown possible protective effects of sodium-glucose co-transporter-2 inhibitors (SGLT-2is) for acute kidney injury (AKI). As SGLT-2is have diuretic properties, uncertainty remains regarding their effect on the risk of AKI during hospital admission, where hypovolemia frequently occurs. Therefore, we assessed the association between (pre)hospital treatment with SGLT-2i and AKI risk in hospitalized patients.

Methods

We performed a matched cohort study. We identified hospitalized patients with prehospital use of SGLT-2i in the Frisius Medical Centre Leeuwarden, between October 21, 2021, and February 12, 2024. These were matched 1:1 to hospitalized patients without prehospital use of SGLT-2i. AKI incidence was the main outcome. Second, SGLT-2i treatment during hospitalization was assessed.

Results

Overall,1,054 hospital admissions were included, 527 with and 527 without prehospital SGLT-2i use. Overall, 34% of patients were women; the median age was 71 years (IQR 65–78). SGLT-2i was indicated for heart failure in 16%, chronic kidney disease 6%, type 2 diabetes 7%, and at least two indications in 72%. Hospital-acquired AKIs occurred in 17.5% admissions with prehospital SGLT-2i treatment and 25.8% among those without (RR = 0.68 [95% CI = 0.53–0.86]). AKI risk was similarly decreased in patients continuing SGLT-2i during hospital admission (RR 0.65 [0.49–0.85]). AKI was associated with increased length of hospital stay (median 7 days, IQR 4–11, versus 3 days, IQR 1–7 without AKI); SGLT-2i use was not. Overall, SGLT-2i treatment did not affect overall mortality. In patients with AKI, mortality was numerically lower in SGLT-2i patients (risk difference = 7.8%, 95% CI –0.9–15.7%), although the confidence interval includes zero.

Conclusion

We observed a 32% lower risk of AKI in hospitalized patients using SGLT-2i at admission. This suggest a protective effect of SGLT-2i against AKI, which remained when SGLT-2i was continued during hospitalization.

Schlagwörter

Stichwörter der Autor:innen

Acute kidney injurySGLT-2i

Autor:innen und Institutionen

  • Department of Nephrology, University Medical Centre Utrecht, Utrecht, The Netherlands, d.g.l.demartines@umcutrecht.nl.
  • Department of Internal Medicine, Frisius Medical Centre, Leeuwarden, The Netherlands.
  • Department of Nephrology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Department of Nephrology, Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.
  • Business Intelligence Competence Center, FrisiusMC, Leeuwarden, The Netherlands.
  • Department of Epidemiology, Frisius Medical Centre, Leeuwarden, The Netherlands.

Zitieren

APA

de Martines, D. G. L., Aydinoglu, K. H. A., Gant, C., Westra, Y., de Jong, K., & Adema, A. Y. (2026). Lower Risk of Acute Kidney Injury in Hospitalized Patients Treated with SGLT-2 Inhibitors: A Retrospective Matched Cohort Study. American Journal of Nephrology, 1-10. https://doi.org/10.1159/000551925

Vancouver

de Martines DGL, Aydinoglu KHA, Gant C, Westra Y, de Jong K, Adema AY. Lower Risk of Acute Kidney Injury in Hospitalized Patients Treated with SGLT-2 Inhibitors: A Retrospective Matched Cohort Study. American Journal of Nephrology. 2026:1-10. doi:10.1159/000551925

BibTeX
@article{deMartines2026,
  author = {de Martines, Dion Gabriël Lodewijk and Aydinoglu, Kenan Hasan Ali and Gant, Christina and Westra, Ytzen and de Jong, Kim and Adema, Aaltje Ymkje},
  title = {Lower Risk of Acute Kidney Injury in Hospitalized Patients Treated with SGLT-2 Inhibitors: A Retrospective Matched Cohort Study},
  journal = {American Journal of Nephrology},
  year = {2026},
  pages = {1--10},
  doi = {10.1159/000551925}
}
Kostenlos starten →